The genetics of transitional cell carcinoma: progress and potential clinical application.
Knowles
M A
MA
ICRF Cancer Medicine Research Unit, St James's University Hospital, Leeds, UK. m.knowles@icrf.icnet.uk
D002295:Carcinoma, Transitional Cell / Q000235:genetics* / Q000628:therapy; D002453:Cell Cycle; D002872:Chromosome Deletion; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D018450:Disease Progression; D016147:Genes, Tumor Suppressor / Q000235:genetics; D015316:Genetic Therapy; D006801:Humans; D019656:Loss of Heterozygosity; D009857:Oncogenes / Q000235:genetics; D016160:Retinoblastoma Protein / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000628:therapy
D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53